Royce & Associates’s Glaukos GKOS Stock Holding History

Royce & Associates’s Portfolio GKOS Stock Details GKOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-25,125	Closed	-$775K	–	1182
2020 Q1	$775K	Hold	25,125	–	–	0.01%	773
2019 Q4	$1.37M	Buy	25,125 +9,125	+57%	+$555K	0.01%	763
2019 Q3	$1M	Buy	+16,000	New	+$1.13M	0.01%	811

Other funds holding GKOS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Royce & Associates's GKOS Position: Q2 2020 in Review

Royce & Associates sold out of Glaukos (GKOS) in Q2 2020, closing a stake of 25,125 shares — an estimated $775K sold.

Royce & Associates first reported a position in GKOS in Q3 2019 and held it in 3 quarters. The position peaked at $1.37M in Q4 2019. 181 funds tracked by Wall St. Rank hold GKOS as of Q2 2020.

Royce & Associates reported no remaining Glaukos position as of Q2 2020 after selling out during the quarter.
Royce & Associates sold 25,125 Glaukos shares in Q2 2020, an estimated $775K.
Royce & Associates first reported a position in Glaukos in Q3 2019 and held it in 3 quarters.
Royce & Associates's Glaukos position peaked at $1.37M in Q4 2019.
181 funds tracked by Wall St. Rank held Glaukos as of Q2 2020.

Based on Royce & Associates's 13F filing for Q2 2020, filed 7 Aug 2020.